Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance.

[1]  T. Terada,et al.  Glandular elements around the intrahepatic bile ducts in man; their morphology and distribution in normal livers. , 2008, Liver.

[2]  Yasunori Sato,et al.  Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture , 2007, Laboratory Investigation.

[3]  Sanjeev Gupta,et al.  Novel hepatic progenitor cell surface markers in the adult rat liver , 2007, Hepatology.

[4]  P. Burgel,et al.  MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. , 2006, The American journal of pathology.

[5]  S. Ho,et al.  Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. , 2006, Gastroenterology.

[6]  Yasunori Sato,et al.  Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. , 2006, The American journal of pathology.

[7]  Y. Nakanuma,et al.  Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis , 2006, Virchows Archiv.

[8]  F. Paulsen,et al.  Mucins and TFF peptides of the tear film and lacrimal apparatus. , 2006, Progress in histochemistry and cytochemistry.

[9]  T. Limpaiboon,et al.  Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis. , 2006, World journal of gastroenterology.

[10]  S. Gendler,et al.  Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. , 2006, Gastroenterology.

[11]  Y. Maehara,et al.  Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour , 2006, Histopathology.

[12]  P. Singh,et al.  RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells , 2006, Clinical Cancer Research.

[13]  H. Weinstein,et al.  Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. , 2006, Gastroenterology.

[14]  F. Paulsen,et al.  Prognostic value of mucins in the classification of ampullary carcinomas. , 2006, Human pathology.

[15]  W. Hoffmann.  Trefoil factors , 2005, Cellular and Molecular Life Sciences CMLS.

[16]  L. Thim,et al.  Structure of mammalian trefoil factors and functional insights. , 2005, Cellular and molecular life sciences : CMLS.

[17]  A. Giraud,et al.  Multiple regulatory pathways for trefoil factor (TFF) genes. , 2005, Cellular and molecular life sciences : CMLS.

[18]  L. Yin,et al.  MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin , 2005 .

[19]  O. Basturk,et al.  Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils , 2005, Modern Pathology.

[20]  N. Ohkohchi,et al.  MUC 1 core protein as a marker of gallbladder malignancy. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  R. Idilman,et al.  Trefoil Factor Expression in Biliary Epithelium of Graft-versus-Host Disease of the Liver after Allogeneic Hematopoietic Cell Transplantation , 2005, Transplantation.

[22]  Y. Nakanuma,et al.  Expression Profiles of MUC Mucin Core Protein in the Intrahepatic Biliary System : Physiological Distribution and Pathological Significance , 2005 .

[23]  M. Nagino,et al.  Aberrant expression of pyloric gland‐type mucin in mucin‐producing bile duct carcinomas: A clear difference between the core peptide and the carbohydrate moiety , 2005, Pathology international.

[24]  S. Ito,et al.  Prediction of Prognosis in Gallbladder Carcinoma by Mucin and p53 Immunohistochemistry , 2005, Digestive Diseases and Sciences.

[25]  T. Tsukamoto,et al.  Sox2 expression in human stomach adenocarcinomas with gastric and gastric‐and‐intestinal‐mixed phenotypes , 2005, Histopathology.

[26]  T. Manabe,et al.  Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss , 2005, The Journal of pathology.

[27]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[28]  M. Koike,et al.  Expression of homeodomain protein CDX2 in gallbladder carcinomas , 2005, Journal of Cancer Research and Clinical Oncology.

[29]  Chang-Hoon Kim,et al.  MUC8 as a ciliated cell marker in human nasal epithelium , 2005 .

[30]  Alphonse E. Sirica,et al.  Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.

[31]  S. Specht,et al.  Regulation and function of trefoil factor family 3 expression in the biliary tree. , 2004, The American journal of pathology.

[32]  N. LaRusso,et al.  The cholangiopathies: disorders of biliary epithelia. , 2004, Gastroenterology.

[33]  A. Dick,et al.  Normal but not altered mucins activate neutrophils , 2004, Cell and Tissue Research.

[34]  Y. Sugiyama,et al.  Immunolocalization of extracellular matrix components and integrins during mouse liver development , 2004, Hepatology.

[35]  N. Schaefer,et al.  Carcinoma of the Ampulla of Vater: Comparative Histologic/Immunohistochemical Classification and Follow-up , 2004, The American journal of surgical pathology.

[36]  Olca Basturk,et al.  Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an “Intestinal” Pathway of Carcinogenesis in the Pancreas , 2004, The American journal of surgical pathology.

[37]  F. May,et al.  The trefoil protein TFF1 is bound to MUC5AC in humangastric mucosa , 2004, Cellular and Molecular Life Sciences.

[38]  Y. Jan,et al.  Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis , 2004, Laboratory Investigation.

[39]  D. Swallow,et al.  The complete genomic organization of the human MUC6 and MUC2 mucin genes. , 2004, Genomics.

[40]  Y. Nakanuma,et al.  Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis , 2004, Peptides.

[41]  D. Thornton,et al.  Identification of Molecular Intermediates in the Assembly Pathway of the MUC5AC Mucin* , 2004, Journal of Biological Chemistry.

[42]  G. Klöppel,et al.  Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas , 2004, Virchows Archiv.

[43]  Friedrich Paulsen,et al.  Human lacrimal gland mucins , 2004, Cell and Tissue Research.

[44]  S. Batra,et al.  Pathologic Features of Mucin-producing Bile Duct Tumors: Two Histopathologic Categories as Counterparts of Pancreatic Intraductal Papillary-mucinous Neoplasms , 2004, The American journal of surgical pathology.

[45]  K. McGlynn,et al.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? , 2004, Journal of hepatology.

[46]  A. Poustka,et al.  Site‐characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor‐1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[47]  Kohzoh Imai,et al.  MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma‐mass forming type , 2004, Hepatology.

[48]  J. Feeney,et al.  Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. , 2003, Biochemistry.

[49]  K. Tsuneyama,et al.  Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. , 2003, Human pathology.

[50]  T. Irimura,et al.  Expression of Different Glycoforms of Membrane Mucin (MUC1) and Secretory Mucin (MUC2, MUC5AC and MUC6) in Pancreatic Neoplasms , 2003 .

[51]  Massimo Loda,et al.  Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway* , 2003, Journal of Biological Chemistry.

[52]  K. Tsuneyama,et al.  Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. , 2003, Gastroenterology.

[53]  K. Tsuneyama,et al.  Aberrant Expression of Trefoil Factor Family 1 in Biliary Epithelium in Hepatolithiasis and Cholangiocarcinoma , 2003, Laboratory Investigation.

[54]  K. Carraway,et al.  PEA3 Transactivates the Muc4/Sialomucin Complex Promoter in Mammary Epithelial and Tumor Cells* , 2003, Journal of Biological Chemistry.

[55]  A. Varki,et al.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. , 2003, The Journal of clinical investigation.

[56]  C. A. Carraway,et al.  Muc4/Sialomucin Complex, the Intramembrane ErbB2 Ligand, Translocates ErbB2 to the Apical Surface in Polarized Epithelial Cells* , 2003, Journal of Biological Chemistry.

[57]  A. Poustka,et al.  Expression of Deleted in Malignant Brain Tumor-1 (DMBT1) Molecule in Biliary Epithelium Is Augmented in Hepatolithiasis: Possible Participation in Lithogenesis , 2003, Digestive Diseases and Sciences.

[58]  N. Tanaka,et al.  Hepatolithiasis--epidemiology and pathogenesis update. , 2003, Frontiers in bioscience : a journal and virtual library.

[59]  G. Gores.  Cholangiocarcinoma: Current concepts and insights , 2003, Hepatology.

[60]  Minoru Fukuda,et al.  Extended Core 1 and Core 2 Branched O-Glycans Differentially Modulate Sialyl Lewis x-type L-selectin Ligand Activity* , 2003, The Journal of Biological Chemistry.

[61]  J. Neuberger,et al.  Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis , 2002, Hepatology.

[62]  Yang Li,et al.  Characterization of Human Ocular Mucin Secretion Mediated by 15(S)-HETE , 2002, Cornea.

[63]  K. Imai,et al.  Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis , 2002, Pathology international.

[64]  S. Crawley,et al.  Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. , 2002, Gastroenterology.

[65]  K. Tsuneyama,et al.  Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. , 2002, The American journal of pathology.

[66]  L. Thim,et al.  Effect of trefoil factors on the viscoelastic properties of mucus gels , 2002, European journal of clinical investigation.

[67]  T. Patel,et al.  Worldwide trends in mortality from biliary tract malignancies , 2002, BMC Cancer.

[68]  M. Kaplan,et al.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. , 2002, The Journal of clinical investigation.

[69]  Tatjana Crnogorac-Jurcevic,et al.  Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. , 2002, The American journal of pathology.

[70]  J. Lüttges,et al.  The Mucin Profile of Noninvasive and Invasive Mucinous Cystic Neoplasms of the Pancreas , 2002, The American journal of surgical pathology.

[71]  Kan Yang,et al.  Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.

[72]  S. Gordon,et al.  Generation of ligand‐receptor alliances by “SEA” module‐mediated cleavage of membrane‐associated mucin proteins , 2002, Protein science : a publication of the Protein Society.

[73]  S. Crawley,et al.  MUC17, a novel membrane-tethered mucin. , 2002, Biochemical and biophysical research communications.

[74]  M. Ulaganathan,et al.  Biliary epithelial trefoil peptide expression is increased in biliary diseases , 2002, Histopathology.

[75]  C. Reis,et al.  Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma , 2002, Virchows Archiv.

[76]  A. Poustka,et al.  Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. , 2001, Cancer research.

[77]  King-Teh Lee,et al.  Altered Mucin Gene Expression in Stone-Containing Intrahepatic Bile Ducts and Cholangiocarcinomas , 2001, Digestive Diseases and Sciences.

[78]  H. Adami,et al.  The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis , 2001, Hepatology.

[79]  Y. Jan,et al.  Intraductal papillary neoplasia of the liver associated with hepatolithiasis , 2001, Hepatology.

[80]  I. van Seuningen,et al.  Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer? , 2001, Frontiers in bioscience : a journal and virtual library.

[81]  L. Yu,et al.  Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis. , 2001, Clinical science.

[82]  L. Yin,et al.  The Epidermal Growth Factor Receptor Regulates Interaction of the Human DF3/MUC1 Carcinoma Antigen with c-Src and β-Catenin* , 2001, The Journal of Biological Chemistry.

[83]  K. Tsuneyama,et al.  Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis , 2001, Histopathology.

[84]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[85]  Y. Sugiyama,et al.  Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi , 2001, Hepatology.

[86]  M. Kudo.  Hepatic peribiliary cysts: clinically harmless disease with potential risk due to gradual increase in size and number , 2001, Journal of Gastroenterology.

[87]  Masanobu Komatsu,et al.  Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor , 2001, Oncogene.

[88]  R. Poulsom,et al.  Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa , 2000, Gut.

[89]  M. Copin,et al.  Developmental Mucin Gene Expression in the Gastroduodenal Tract and Accessory Digestive Glands. II. Duodenum and Liver, Gallbladder, and Pancreas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[90]  L. Aaltonen,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[91]  D. Swallow,et al.  Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. , 2000, Biochemical and biophysical research communications.

[92]  H. S. Kim,et al.  Somatic mutations of the trefoil factor family 1 gene in gastric cancer. , 2000, Gastroenterology.

[93]  N. Porchet,et al.  Evolution of the large secreted gel-forming mucins. , 2000, Molecular biology and evolution.

[94]  M. Hollingsworth,et al.  Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. , 2000, Journal of biochemistry.

[95]  D. Taupin,et al.  Distinct Pathways of Cell Migration and Antiapoptotic Response to Epithelial Injury: Structure-Function Analysis of Human Intestinal Trefoil Factor , 2000, Molecular and Cellular Biology.

[96]  K. Chayama,et al.  Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis , 2000, Cancer.

[97]  H. Jung,et al.  Expression of Mucin Genes in Chronic Ethmoiditis , 2000, American journal of rhinology.

[98]  T. Irimura,et al.  Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity. , 1999, Journal of biochemistry.

[99]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma , 1999, Hepatology.

[100]  N. McNamara,et al.  Control of mucin transcription by diverse injury-induced signaling pathways. , 1999, American journal of respiratory and critical care medicine.

[101]  A. Corfield,et al.  Secreted human conjunctival mucus contains MUC5AC glycoforms. , 1999, Glycobiology.

[102]  D. Swallow,et al.  Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin. , 1999, Biochemical and biophysical research communications.

[103]  D. Gotley,et al.  Two novel mucin genes down-regulated in colorectal cancer identified by differential display. , 1999, Cancer research.

[104]  Y. Nakanuma,et al.  Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction. , 1999, Liver.

[105]  N. Smorodinsky,et al.  MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer , 1999, International journal of cancer.

[106]  H. Kohli,et al.  CT of Liver Cysts in Patients with Autosomal Dominant Polycystic Kidney Disease , 1999, Acta radiologica.

[107]  G. Stamp,et al.  Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[108]  Y. Nakanuma,et al.  Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study , 1999, The Journal of pathology.

[109]  M. Hollingsworth,et al.  Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[110]  J. Wright,et al.  Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. , 1999, American journal of respiratory cell and molecular biology.

[111]  T. Welte,et al.  Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. , 1999, American journal of respiratory and critical care medicine.

[112]  C. Epstein,et al.  Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[113]  R. Bresalier,et al.  Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. , 1999, Gastroenterology.

[114]  Jacqueline Capeau,et al.  Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras , 1999, Oncogene.

[115]  Y. Nakanuma,et al.  Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non‐dysplastic epithelia of the gallbladder , 1999, Pathology international.

[116]  G. Niehans,et al.  The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues , 1998, The Journal of pathology.

[117]  E. Keeffe,et al.  Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. , 1998, The Journal of clinical investigation.

[118]  J. Olsen,et al.  Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark , 1998, Hepatology.

[119]  D. Thornton,et al.  Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association. , 1998, The Biochemical journal.

[120]  Y. Nakanuma,et al.  Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis , 1998, The Journal of pathology.

[121]  J. Dagorn,et al.  Expression of the Cdx1 and Cdx2 Homeotic Genes Leads to Reduced Malignancy in Colon Cancer-derived Cells* , 1998, The Journal of Biological Chemistry.

[122]  J. van Marle,et al.  MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonic goblet cells. , 1998, The American journal of physiology.

[123]  Y. Kim,et al.  Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. , 1998, American journal of clinical pathology.

[124]  Y. Kim,et al.  Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction , 1998, Hepatology.

[125]  B. Clement,et al.  Mucin gene expression in biliary epithelial cells. , 1997, Journal of hepatology.

[126]  B. Macpherson,et al.  Ground squirrel model for cholelithiasis: Role of epithelial glycoproteins , 1997, Microscopy research and technique.

[127]  Jan Mollenhauer,et al.  DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours , 1997, Nature Genetics.

[128]  I. van Seuningen,et al.  Genomic Organization of the 3′ Region of the Human Mucin GeneMUC5B * , 1997, The Journal of Biological Chemistry.

[129]  B. Paigen,et al.  Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. , 1997, Journal of lipid research.

[130]  R. Bresalier,et al.  Liver endothelial E‐selectin mediates carcinoma cell adhesion and promotes liver metastasis , 1997, International journal of cancer.

[131]  N. Afdhal,et al.  Molecular cloning of a major human gall bladder mucin: complete C-terminal sequence and genomic organization of MUC5B. , 1997, The Biochemical journal.

[132]  E. Schlaepfer,et al.  Improved In Situ Hybridization to HIV with RNA Probes Derived from PCR Products , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[133]  N. Nowak,et al.  Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. , 1997, American journal of respiratory cell and molecular biology.

[134]  S. Dooley,et al.  The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3. , 1997, Genomics.

[135]  N. Porchet,et al.  Human Mucin Gene MUC5B, the 10.7-kb Large Central Exon Encodes Various Alternate Subdomains Resulting in a Super-repeat , 1997, The Journal of Biological Chemistry.

[136]  D. Swallow,et al.  Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. , 1996, Genomics.

[137]  Y. Kim,et al.  Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: An immunohistochemical study , 1996, Hepatology.

[138]  M. Fishman,et al.  Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.

[139]  P. Chambon,et al.  Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.

[140]  T. Lesuffleur,et al.  Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations. , 1996, European journal of cancer.

[141]  Y. Nakanuma,et al.  Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases , 1996, Hepatology.

[142]  H. Shizuya,et al.  Cloning of contiguous genomic fragments from human chromosome 21 harbouring three trefoil peptide genes , 1996, Human Genetics.

[143]  Y. Nakanuma,et al.  Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: An immunohistochemical study , 1996, Hepatology.

[144]  Patricia A. Gabow,et al.  PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.

[145]  R. Poulsom,et al.  Molecular aspects of restitution: functions of trefoil peptides. , 1996, The Yale journal of biology and medicine.

[146]  R. Poulsom,et al.  The gene encoding human intestinal trefoil factor (TFF3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family. , 1996, Genomics.

[147]  T. Shows,et al.  Structure and chromosomal localization of the human salivary mucin gene, MUC7. , 1996, Genomics.

[148]  L. Johnson.  Liver biopsy interpretation 5th ed , 1996 .

[149]  W. Joba,et al.  Biosynthesis and molecular architecture of gel-forming mucins: implications from an amphibian model system. , 1995, Biochemical Society transactions.

[150]  R. Colombari,et al.  Biliary Tumors of the Liver , 1995, Seminars in liver disease.

[151]  Y. Kim,et al.  Diversity of mucin genes, structure, function, and expression. , 1995, Gastroenterology.

[152]  T. Terada,et al.  Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study. , 1995, The American journal of pathology.

[153]  G. Young,et al.  Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. , 1995, The American journal of pathology.

[154]  J. Ferlay,et al.  Cancer incidence in Thailand, 1988-1991. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[155]  K. Tsuneyama,et al.  Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[156]  Y. Nakanuma,et al.  Expression of Mucin core protein of mammary type in primary liver cancer , 1994, Hepatology.

[157]  L. Thim,et al.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. , 1994, The Journal of clinical investigation.

[158]  Siep Thomas,et al.  THE POLYCYSTIC KIDNEY-DISEASE-1 GENE ENCODES A 14-KB TRANSCRIPT AND LIES WITHIN A DUPLICATED REGION ON CHROMOSOME-16 , 1994 .

[159]  T. Terada,et al.  Intrahepatic cholangiocarcinomas associated with nonbiliary cirrhosis. A clinicopathologic study. , 1994, Journal of clinical gastroenterology.

[160]  R. Bacallao,et al.  Biology of polycystic kidney disease. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[161]  T. Terada,et al.  Intrahepatic peribiliary glands of humans. II. Pathological spectrum , 1994, Journal of gastroenterology and hepatology.

[162]  Y. Nakanuma,et al.  Neoexpression of Lewis Y antigen is a sensitive phenotypic change of the damaged intrahepatic bile ducts , 1994, Hepatology.

[163]  P. Gabow.  Introduction: Autosomal Dominant Polycystic Kidney Disease , 1993 .

[164]  A. Biesbrock,et al.  Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). , 1993, The Journal of biological chemistry.

[165]  K. Imai,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma , 1993, International journal of cancer.

[166]  R. Poulsom,et al.  hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[167]  P. Gabow,et al.  Autosomal dominant polycystic kidney disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[168]  C. Melief,et al.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. , 1993, Journal of immunology.

[169]  K. Chayama,et al.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.

[170]  Y. S. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors , 1993, Cancer.

[171]  W. Kuo,et al.  Human gastric mucin. Identification of a unique species by expression cloning. , 1993, The Journal of biological chemistry.

[172]  V. Desmet.  Congenital diseases of intrahepatic bile ducts: Variations on the theme “ductal plate malformation” , 1992, Hepatology.

[173]  T. Terada,et al.  Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: An autopsy study , 1992, Hepatology.

[174]  N. Peat,et al.  Structure and biology of a carcinoma-associated mucin, MUC1. , 1991, The American review of respiratory disease.

[175]  R. Bast,et al.  Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. , 1991, Cancer research.

[176]  R. Dahiya,et al.  Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. , 1991, The Journal of clinical investigation.

[177]  M. Gross,et al.  Assignment of human tracheobronchial mucin gene(s) to 11p15 and a tracheobronchial mucin-related sequence to chromosome 13 , 1990, Human Genetics.

[178]  T. Terada,et al.  ‘Metaplastic lesions’ in intrahepatic bile ducts in hepatolithiasis: A histochemical and immunohistochemical study , 1990, Journal of gastroenterology and hepatology.

[179]  J. Attwood,et al.  Assignment of the polymorphic intestinal mucin gene (MUC2) to chromosome 11p15 , 1990, Annals of human genetics.

[180]  D. Swallow,et al.  Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. , 1990, Biochemical and biophysical research communications.

[181]  Ann M. Johnson,et al.  Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease , 1990, Hepatology.

[182]  R. Lathe,et al.  hSP, the domain‐duplicated homolog of pS2 protein, is co‐expressed with pS2 in stomach but not in breast carcinoma. , 1990, The EMBO journal.

[183]  M. Gerber,et al.  Development of intrahepatic bile ducts in humans. Immunohistochemical study using monoclonal cytokeratin antibodies. , 1989, Archives of pathology & laboratory medicine.

[184]  Y. Nakanuma,et al.  Expression of blood group‐related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases , 1989, Hepatology.

[185]  P. Bhathal,et al.  Morphological and immunohistochemical assessment of intrahepatic bile duct development in the rat , 1989, Journal of gastroenterology and hepatology.

[186]  Y. Kim,et al.  Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. , 1989, The Journal of biological chemistry.

[187]  Y. Nakanuma,et al.  Endocrine cells in the intrahepatic biliary tree in normal livers and hepatolithiasis. , 1989, Archives of pathology & laboratory medicine.

[188]  P. van Eyken,et al.  The development of the intrahepatic bile ducts in man: A keratin‐immunohistochemical study , 1988, Hepatology.

[189]  J. Guest,et al.  Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[190]  T. Terada,et al.  Pathologic features of hepatolithiasis in Japan. , 1988, Human pathology.

[191]  J. Brody,et al.  Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[192]  J. Taylor‐Papadimitriou,et al.  Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. , 1987, Cancer research.

[193]  R. N. Macsween,et al.  Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease. , 1987, Journal of clinical pathology.

[194]  I. Mackay,et al.  Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. , 1987, Journal of immunology.

[195]  R. Macsween.  Pathology of the Liver , 1981 .

[196]  M. Kaplan,et al.  Primary Biliary Cirrhosis , 1987, The New England journal of medicine.

[197]  P. Verdugo,et al.  Molecular mechanism of product storage and release in mucin secretion. II. The role of extracellular Ca++. , 1986, Biorheology.

[198]  T. Terada,et al.  Are hepatolithiasis and cholangiocarcinoma aetiologically related? , 1985, Virchows Archiv A.

[199]  N. Shiojiri.  The origin of intrahepatic bile duct cells in the mouse. , 1984, Journal of embryology and experimental morphology.

[200]  H. Spiro,et al.  Liver Biopsy Interpretation (3rd ed.) , 1983 .

[201]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[202]  W. Bodmer,et al.  Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in culture , 1981, International journal of cancer.

[203]  L. Agodoa,et al.  Liver cysts in patients with autosomal dominant polycystic kidney disease. , 1980, The American journal of medicine.

[204]  Y. Nakanuma,et al.  Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis , 1979 .

[205]  R. Soloway,et al.  Pigment vs cholesterol cholelithiasis: Comparison of stone and bile composition , 1974, The American Journal of Digestive Diseases.

[206]  P. Steiner,et al.  Cholangiolocellular carcinoma of the liver , 1959, Cancer.

[207]  C. Ker,et al.  Hepatolithiasis in East Asia retrospective study , 2005, Digestive Diseases and Sciences.

[208]  R. Bresalier,et al.  Mucins and mucin binding proteins in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[209]  I. Gipson,et al.  Differential regulation of membrane-associated mucins in the human ocular surface epithelium. , 2004, Investigative ophthalmology & visual science.

[210]  D. Thornton,et al.  From mucins to mucus: toward a more coherent understanding of this essential barrier. , 2004, Proceedings of the American Thoracic Society.

[211]  W. Jagla,et al.  Molecular medicine of TFF-peptides: from gut to brain. , 2001, Histology and histopathology.

[212]  E. Keeffe,et al.  The immunopathology of primary biliary cirrhosis: thoughts for the millennium. , 2000, Archivum immunologiae et therapiae experimentalis.

[213]  H. Itoh,et al.  Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. , 2000, Gastroenterology.

[214]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[215]  C. Tomasetto,et al.  pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. , 2000, Gastroenterology.

[216]  P. Sithithaworn,et al.  Liver flukes and liver cancer , 1999 .

[217]  Y. Nakanuma,et al.  Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[218]  M. Buisine,et al.  Evolutionary History of the 11p15 Human Mucin Gene Family , 1998, Journal of Molecular Evolution.

[219]  日本肝癌研究会.  Classification of primary liver cancer , 1997 .

[220]  N. Blin,et al.  Human Trefoil Peptides: Genomic Structure in 21q22.3 and Coordinated Expression , 1996, European journal of human genetics : EJHG.

[221]  V. Debailleul,et al.  Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? , 1995, The Biochemical journal.

[222]  R. Playford,et al.  Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. , 1995, Gastroenterology.

[223]  J. Ludwig,et al.  The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. , 1990, Archives of pathology & laboratory medicine.

[224]  S. Sherlock,et al.  Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. , 1986, Journal of hepatology.

[225]  J. Schlom,et al.  Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. , 1984, Hybridoma.

[226]  F. Matsubara,et al.  A Study of Hepatolithiasis Associated with Cholangiocarcinoma , 1978 .

[227]  W. Bloom.  The embryogenesis of human bile capillaries and ducts , 1926 .